NCT06451497 2024-12-04Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid TumorsZumutor Biologics Inc.Phase 1 Recruiting33 enrolled
NCT03999658 2023-05-01A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory MalignanciesSorrento Therapeutics, Inc.Phase 2 Withdrawn